Alterations in the mismatch repair (MMR) system result in genomic instability, neoantigen production, and immune response in cancer. There is evidence that gastroesophageal tumors with MMR deficiency may be susceptible to immune-checkpoint inhibitors treatment, especially in those presenting at advanced-stage disease. Although a number of biomarkers have been developed in histology-agnostic settings to assess MMR status, there is evidence that a tumor-specific testing approach would improve the selection of patients for immunotherapy. However, no testing methods have been developed specifically for gastroesophageal cancers so far. Here, we discuss the state of the art, current advances, and future perspectives of MMR-related biomarkers’ biologic and clinical role in gastroesophageal cancers
Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing / G. Lopez, K. Venetis, E. Sajjadi, N. Fusco. - In: GASTROINTESTINAL DISORDERS. - ISSN 2624-5647. - 2:4(2020), pp. 341-352. [10.3390/gidisord2040031]
Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical Testing
G. LopezPrimo
;K. VenetisSecondo
;E. SajjadiPenultimo
;N. Fusco
Ultimo
2020
Abstract
Alterations in the mismatch repair (MMR) system result in genomic instability, neoantigen production, and immune response in cancer. There is evidence that gastroesophageal tumors with MMR deficiency may be susceptible to immune-checkpoint inhibitors treatment, especially in those presenting at advanced-stage disease. Although a number of biomarkers have been developed in histology-agnostic settings to assess MMR status, there is evidence that a tumor-specific testing approach would improve the selection of patients for immunotherapy. However, no testing methods have been developed specifically for gastroesophageal cancers so far. Here, we discuss the state of the art, current advances, and future perspectives of MMR-related biomarkers’ biologic and clinical role in gastroesophageal cancersFile | Dimensione | Formato | |
---|---|---|---|
[2020] MMR and GEC gastrointestdisord-02-00031 (1).pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.51 MB
Formato
Adobe PDF
|
1.51 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.